New! Sign up for our free email newsletter.
Reference Terms
from Wikipedia, the free encyclopedia

Bitemporal hemianopsia

Bitemporal hemianopsia (or Bitemporal hemianopia) is the medical description of a type of partial blindness where vision is missing in the outer half of both the right and left visual field. It is usually associated with lesions of the optic chiasm, the area where the optic nerves from the right and left eyes cross near the pituitary gland.

In bitemporal hemianopsia vision is missing in the outer (temporal or lateral) half of both the right and left visual fields. Information from the temporal visual field falls on the nasal (medial) retina. The nasal retina is responsible for carrying the information along the optic nerve, and crosses to the other side at the optic chiasm. When there is compression at optic chiasm the visual impulse from both nasal retina are affected, leading to inability to view the temporal, or peripheral, vision. This phenomenon is known as bitemporal hemianopsia. Knowing the neurocircuitry of visual signal flow through the optic tract is very important in understanding bitemporal hemianopsia.

Bitemporal hemianopsia most commonly occurs as a result of tumors located at the mid-optic chiasm. Since the adjacent structure is the pituitary gland, some common tumors causing compression are Pituitary adenomas, and Craniopharyngiomas. Also another relatively common neoplastic etiology is Meningiomas.

The absence of vision in half of a visual field is described as hemianopsia.

The visual field of each eye can be divided in two vertically, with the outer half being described as temporal, and the inner half being described as nasal.

"Bitemporal hemianopsia" can be broken down as follows:

bi-: involves both left and right visual fields

temporal: involves the temporal visual field

hemi-: involves half of each visual field

anopsia: blindness

Related Stories
 


Health & Medicine News

May 29, 2026

Scientists at Stanford may have uncovered a hidden reason our brains decline with age. Studying the ultra-short-lived turquoise killifish, researchers discovered that the cellular machinery responsible for building proteins begins to jam and ...
Using cannabis edibles and alcohol together may make drivers far more impaired than either substance alone, according to new research from Johns Hopkins. Even more concerning, common field sobriety tests often failed to detect the cannabis-related ...
A sweeping global study found that chronic kidney disease now affects nearly 800 million people and has become one of the world's leading causes of death. Often silent in its early stages, the condition is also a major contributor to heart disease ...
Feeling constantly drained might not just be about poor sleep or working too hard. Researchers in Japan found that low levels of key vitamins — especially vitamin B12 and folate — may quietly contribute to fatigue and lack of motivation, even in ...
Cambridge researchers created miniature brain-and-spinal-cord systems in the lab that can send signals and even trigger tiny muscle contractions. They discovered that human neurons gradually lose their ability to regrow after damage during ...
CBD may be doing far more than just easing pain or anxiety — new research suggests it could help fight Alzheimer’s disease by calming the brain’s runaway immune response. In experiments using Alzheimer’s mice, scientists found that inhaled ...
Researchers are developing a futuristic alternative to LASIK that reshapes the eye without lasers or incisions. Using mild electrical pulses and platinum contact lenses, they temporarily soften the cornea so it can be molded into a new shape. Early ...
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to ...
A new brain imaging study has found no evidence of widespread brain inflammation in patients suffering from prolonged symptoms after COVID-19 infection. Instead, the most severe long COVID symptoms ...
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for ...
When the body runs low on protein, the gut sends powerful signals to the brain that reshape cravings and push animals to seek essential amino acids instead of sugar. Researchers say this newly discovered gut-brain network could transform our ...
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease affecting millions worldwide. The experimental drug, ION224, blocks a liver enzyme that drives fat buildup and inflammation, two ...

Latest Headlines

updated 12:56 pm ET